Axiom Investment Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1513703 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$801,374

+$124,315 QoQ

Shares Held

6,343

+30.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#1,165

of 2,266 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Axiom Investment Management LLC holds $9,628,805 across 10 Drug Manufacturers - General names. GILD ranks #7 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	86,053	$2,072,142
2	LLY	ELI LILLY & Co	1,400	$1,679,191
3	BMY	Bristol Myers Squibb Co	23,292	$1,342,081
4	ABBV	AbbVie Inc.	4,806	$1,209,381
5	JNJ	Johnson & Johnson	3,978	$1,010,288
6	MRK	Merck & Co., Inc.	6,417	$824,580
7	GILD	Gilead Sciences, Inc. This page	6,343	$801,374
8	NVS	Novartis AG	3,326	$521,249

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$801,374	6,343	+30.6%	Shares	Sole	2026-07-31
2026-03-31	$677,059	4,858	-32.5%	Shares	Sole	2026-05-26
2022-12-31	$617,689	7,195	-34.7%	Shares	Sole	2023-02-14
2022-09-30	$679,438	11,014	-17.0%	Shares	Sole	2022-11-14
2022-06-30	$819,768	13,263	-77.4%	Shares	Sole	2022-08-15
2022-03-31	$3,490,178	58,708	-6.5%	Shares	Sole	2022-05-13
2021-12-31	$4,557,786	62,771	-13.6%	Shares	Sole	2022-02-02
2021-09-30	$5,076,477	72,677	+3.3%	Shares	Sole	2021-10-18
2021-06-30	$4,843,602	70,340	+32.4%	Shares	Sole	2021-08-16
2021-03-31	$3,433,975	53,133	+10078.7%	Shares	Sole	2021-05-20
2020-12-31	$30,411	522	-83.4%	Shares	Sole	2021-02-11
2020-03-31	$234,895	3,142	—	Shares	Sole	2021-03-16
No filing history on record for this holder in this stock.